Concentration Tables, Not Dosing Tables: Keeping Methods-Week Documentation Strictly In Vitro

Methods-writing weeks have a particular rhythm. Protocols are pulled apart, dilution schemes re-derived, and someone eventually asks a question that sounds simple: what concentration are we actually testing? The answer belongs in a laboratory document — a stock solution record, a working-concentration table, an assay worksheet — and nowhere else. The distance between a concentration plan and a dosing instruction looks narrow on paper and is wide in consequence, and methods week is when it is easiest to blur.

Why a Concentration Plan Is a Laboratory Document, Not a Dosing Instruction

A concentration plan records how a material will be prepared and delivered to an experimental system — a well, a cuvette, a perfusion chamber, a culture plate. It states the mass of lyophilised powder in the vial, the volume of diluent added, the resulting stock concentration, the serial dilution scheme, the nominal final concentration in the assay, and the vehicle control that accompanies each level. Those quantities carry meaning only inside a defined experimental design. Detached from that design, a table of numbers can begin to look like something it is not.

That is where ambiguity creeps in during a busy week. Drafts circulate, shorthand appears, and a column headed dose survives into a final SOP because nobody questioned it. Good practice is to strike the word out early and use final assay concentration, nominal concentration, treatment level in vitro or exposure concentration in culture instead. Reserve terms such as subject, administration and dose for documents that have nothing to do with a research catalogue.

The terminology matters because of what the material is. Research Sciences supplies research-use-only products for controlled laboratory and analytical work. Its stated position is that items are labelled “For Research Use Only – Not for Human Consumption”, described as being in line with MHRA guidance; they are not medicines, medical devices, injectables, treatments or food supplements, and the shop states plainly that it does not provide therapeutic, medical, performance, injection, ingestion or dosing guidance. Orders inconsistent with those compliance standards may be refused. A methods document that reads like a dosing schedule sits badly against that status and invites misinterpretation by anyone who later opens the file — a new postgraduate, an audit reviewer, a collaborator at another site.

There is a second, quieter reason to keep the boundary firm: reproducibility. A plan that names the diluent, the volume, the vessel and the handling temperature can be repeated. A plan that defers to “standard practice” cannot. Write for the reader who has the workbook and nothing else, and the concentration table becomes a genuine laboratory asset rather than a source of confusion.

Building a Defensible Concentration Plan During Methods Week

Start from the vial, not the spreadsheet

Lyophilised research peptides should be allowed to reach ambient temperature before opening, handled in a clean environment, and reconstituted only with the amount required for the experiment. Diluents such as the 10 ml Mixing Water or Bacteriostatic Water listings are supplied separately from the peptide, so the methods draft needs to name both components explicitly. Record the trace mannitol content described in the shop’s FAQs — an excipient used for stability during lyophilisation and solubility — because a matched vehicle control should reflect what is actually in the vial, not an assumption about a pure powder.

Use the calculator as a check, never as an instruction

The free reconstitution calculator described on product pages and in the FAQs works in mg, mcg and mL with U-100 and U-50 syringe scales, plus optional IU conversions where a conversion factor is known. Its output is a starting figure for in-vitro laboratory work only and must not be used for human or veterinary dosing. In a methods section, cross-check the arithmetic against volumetric glassware and the assay design, then document the checked value rather than the raw output.

Document storage and handling as part of the method

Lyophilised material is stored at −20°C or below, sealed with desiccant and protected from moisture, heat and light, with repeated freeze–thaw cycles avoided; reconstituted material is less stable and is held at 2–8°C for short-term laboratory use. Note how many freeze–thaw events each aliquot experienced, or move to single-use aliquots and say so. The shop does not supply blended peptides and recommends purchasing individual items and combining only within a controlled experimental design — so a two-component comparison should be written as two separately traceable stock preparations plus a defined combination step.

Traceability, Batch Documentation and the Materials Manager’s Checklist

During methods week, concentration entries are only as strong as the documentation behind them. The shop’s FAQs describe a Certificate of Analysis for every product, covering purity and identity by HPLC, with compounds produced by solid-phase peptide synthesis and independently tested before final UK verification; the About page additionally describes purity, identity, heavy metals and endotoxin evaluation of submitted samples. Where a homepage figure is quoted — such as ≥99% verified purity, order counts or delivery wording — treat it as the shop’s current published wording and reconfirm it on the live site and, where relevant, on the batch CoA itself. The homepage lists “CoAs Janoshik Analytical Reports”; open and check the certificate that accompanies the specific batch rather than relying on a category description.

Two details regularly trip up documentation handovers. Restocked products may carry the same Internal Test Reference as earlier stock, and an ITR links to associated sample testing reports — it does not confirm that separate deliveries came from the same production lot or that they received separate independent testing. Separately, vial cap colours and other packaging may vary; cap colour is not an indicator of identity, analytical quality or manufacturing origin. Vial labels use a SKU-plus-expiry reference format, for example BPC10-03/27, which maps to the corresponding CoA and should be quoted whenever documentation is queried.

Where a new analyte enters the plan mid-week, the pragmatic move is to review the current catalogue before committing anything to the draft. Teams can Buy peptides from the all-products listing, then open the individual product page and its batch CoA to confirm what the certificate actually states. A materials manager’s checklist for each concentration entry therefore looks like this: catalogue SKU and full vial label reference, CoA on file, diluent identified, preparation date, storage history since receipt, and the named assay the stock feeds. Fulfilment details belong in the same file where they affect timing — orders are dispatched the next working day, shipped by Royal Mail Tracked 24, which the carrier estimates will usually arrive the following working day, with tracking issued after dispatch and times varying in peak periods. Returns are not accepted once dispatched given the specialist and perishable nature of the goods, with refunds limited to damage, incorrect supply or quality issues under the published policy, and payment is handled through Pay-By-Bank / Open Banking rather than cards because research-use-only materials fall into high-risk merchant categories; the shop states it does not store bank login details.

Finally, the purchaser remains responsible for lawful use, safe handling, storage and disposal, and for compliance with relevant UK regulations including COSHH and laboratory safety standards. Every entry in the concentration plan should therefore carry the same reminder that the materials are not for human or veterinary use, are not for consumption, administration or clinical application, and exist only to support an in-vitro experiment whose methods section can be read, repeated and audited without ambiguity.

By Isabelle McAllister

Cape Town humanitarian cartographer settled in Reykjavík for glacier proximity. Izzy writes on disaster-mapping drones, witch-punk comic reviews, and zero-plush backpacks for slow travel. She ice-climbs between deadlines and color-codes notes by wind speed.